The TRPS1 transcription factor: Androgenic regulation in prostate cancer and high expression in breast cancer

Endocrine-Related Cancer

Volumn 11, Issue 4, 2004, Pages 815-822

  Chang, Glenn T G ^a   Jhamai, Mila ^a   Van Weerden, Wytske M ^b   Jenster, Guido ^b   Brinkmann, Albert O ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TRPS1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER MODEL; CASTRATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE MUTATION; HISTOPATHOLOGY; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE LEVEL; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; METRIBOLONE; MICE; MICE, INBRED STRAINS; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; RNA, MESSENGER; TESTOSTERONE CONGENERS; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 11244327613     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.00853     Document Type: Article

References (29)

1. Arnold JT & Isaacs JT 2002 Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault. Endocrine-Related Cancer 9 61-73.
2. Chang GTG, Blok LJ, Steenbeek M, Veldscholte J, van Weerden WM, van Steenbrugge GJ & Brinkmann AO 1997 Differentially expressed genes in androgen-dependent and - independent prostate carcinomas. Cancer Research 57 4075-4081.
3. Chang GTG, Steenbeek M, Schippers E, Blok LJ, van Weerden WM, van Alewijk DC, Bussen BH, van Steenbrugge GJ & Brinkmann AO 2000 Characterization of a zinc-finger protein and its association with apoptosis in prostate cancer cells. Journal of the National Cancer Institute 92 1414-1421.
4. Chang GTG, van den Bemd GJ, Jhamai M & Brinkmann AO 2002. Structure and function of GC79/TRPS1, a novel androgen-repressible apoptosis gene. Apoptosis 7 13-21.
5. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB & Jensen RH 1996 Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Research 56 3091-3102.
6. Culig Z, Klocker H, Bartsch G & Hobisch A 2002 Androgen receptors in prostate cancer. Endocrine-Related Cancer 9 155-170.
7. Feldman BJ & Feldman D 2001 The development of androgen-independent prostate cancer. Nature Reviews Cancer 1 34-45.
8. Gelmann EP 2002 Molecular biology of the androgen receptor. Journal of Clinical Oncology 20 3001-3015.
9. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA & Murphy GP 1983 LNCaP model of human prostatic carcinoma. Cancer Research 43 1809-1818.
10. Huggins C & Hodges CV 1941 Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research 1 293-297.
11. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ & Thun MJ 2004 Cancer statistics. CA: A Cancer Journal for Clinicians 54 8-29.
12. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF & Jones LW 1979 Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Investigative Urology 17 16-23.
13. Kaiser FJ, Tavassoli K, Van den Bemd GJ, Chang GTG, Horsthemke B, Möröy T & Lüdecke HJ 2003a Nuclear interaction of the dynein light chain LC8a with the TRPS1 transcription factor suppresses the transcriptional repression activity of TRPS1. Human Molecular Genetics 12 1349-1358.
14. Kaiser FJ, Möröy T, Chang GTG, Horsthemke B & Lüdecke HJ 2003b The RING finger protein RNF4, a co-regulator of transcription, interacts with the TRPS1 transcription factor. Journal of Biological Chemistry 278 38780-38785.
15. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW & Waldman FM 1994 Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. PNAS 91 2156-2160.
16. Lüdecke HJ, Schaper J, Meinecke P, Momeni P, Gross S, von Holtum D, Hirche H, Abramowicz MJ, Albrecht B, Apacik C, Christen HJ, Claussen U, Devriendt K, Fastnacht E, Forderer A, Friedrich U, Goodship TH, Greiwe M, Hamm H, Hennekam RC, Kinkel GK, Hoeltzenbein M, Kayserili H, Majewski F, Mathieu M, McLeod R, Midro AT, Moog U, Nagai T, Niikawa N, Orstavik KH, Plochl E, Seitz C, Schmidtke J, Tranebjaerg L, Tsukahara M, Wittwer B, Zabel B, Gillessen-Kaesbach G & Horsthemke B 2001 Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III. American Journal of Human Genetics 68 81-91.
17. Malik TH, Shoichet SA, Latham P, Kroll TG, Peters LL & Shivdasani RA 2001 Transcriptional repression and developmental functions of the atypical vertebrate GATA protein TRPS1. European Molecular Biology Organization Journal 20 1715-1725.
18. Martel CL, Gumerlock PH, Meyers FJ & Lara PN 2003 Current strategies in the management of hormone refractory prostate cancer. Cancer Treatment Reviews 29 171-187.
19. Moilanen AM, Poukka H, Karvonen U, Hakli M, Janne OA & Palvimo JJ 1998 Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Molecular and Cellular Biology 18 5128-5139.
20. Momeni P, Glockner G, Schmidt O, von Holtum D, Albrecht B, Gillessen-Kaesbach G, Hennekam R, Meinecke P, Zabel B, Rosenthal A, Horsthemke B & Lüdecke HJ 2000 Mutations in a new gene, encoding a zinc-finger protein, cause tricho-rhino-phalangeal syndrome type I. Nature Genetics 24 71-74.
21. Nupponen NN, Kakkola L, Koivisto P & Visakorpi T 1998 Genetic alterations in hormone-refractory recurrent prostate carcinomas. American Journal of Pathology 153 141-148.
22. Savinainen KJ, Linja MJ, Saramki OR, Tammela TLJ, Chang GTG, Brinkmann AO & Visakorpi T 2004 Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer. British Journal of Cancer 90 1041-1046.
23. Stone KR, Mickey DD, Wunderli H, Mickey GH & Paulson DF 1978 Isolation of a human prostate carcinoma cell line (DU 145). International Journal of Cancer 21 274-281.
24. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J & Kallioniemi OP 1998 Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes and Cancer 21 177-184.
25. van den Bemd GJ, Jhamai M, Brinkmann AO & Chang GTG 2003 The atypical GATA protein TRPS1 represses androgen-induced prostate-specific antigen expression in LNCaP prostate cancer cells. Biochemical and Biophysical Research Communications 312 578-584.
26. van Weerden WM & Romijn JC 2000 Use of nude mouse xenograft models in prostate cancer research. Prostate 43 263-271.
27. van Weerden WM, de Ridder CM, Verdaasdonk CL, Romijn JC, van der Kwast TH, Schröder FH & van Steenbrugge GJ 1996 Development of seven new human prostate tumor xenograft models and their histopathological characterization. American Journal of Pathology 149 1055-1062.
28. Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ & Kallioniemi OP 1995 Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Research 55 342-347.
29. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN & Edwards BK 2003 Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. Journal of the National Cancer Institute 95 1276-1299.